Mashail Manzur
Podiatrist · Tucker, GANPI 1689107807
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Stryker at 39.7% of the total. Reporting peaked in 2019 at $4,978 and has fallen 99.5% since, to $25 in 2025.
Across 74 payments — averaging $90.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Southern Edge Orthopaedics, Inc.$2K
- Amniox Medical, Inc.$784
- Biotissue Holdings Inc.$356
- Medical Device Business Services, Inc.$320
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$144
- plus $570 from 16 others
What the payments were for
- Consulting fees$571%
- Speaking & faculty fees$911%
- Travel & lodging$1,38921%
- Food & beverage$2,96444%
- Education$2,16432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 37 | $2,645 |
| Southern Edge Orthopaedics, Inc. | 1 | $1,844 |
| Amniox Medical, Inc. | 8 | $784 |
| Biotissue Holdings Inc. | 2 | $356 |
| Medical Device Business Services, Inc. | 2 | $320 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $144 |
| Organogenesis Inc. | 1 | $91 |
| KCI USA, Inc. | 2 | $81 |
| Baxter Healthcare | 2 | $64 |
| Pfizer | 1 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Johnson & Johnson | 3 | $37 |
| Zimmer Biomet | 1 | $31 |
| Vital Connect, Inc | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Acell, Inc. | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $21 |
| Zimvie Inc. | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Celularity Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,663 in reported general payments places this provider in the 80th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 79 | $2,143 |
| Ciclopirox | 72 | $2,018 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 59 | $971 |
| Methylprednisolone | 24 | $102 |
| Meloxicam | 49 | $78 |
| Gabapentin | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tucker
- John RuchTucker$14K
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
- Stephen BarrettMarietta$82K
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Ryan FitzgeraldCanton$43K
- Margo JimenezAtlanta$19K
- Samantha MinerSmyrna$17K
- Robson SpinolaJesup$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.